The FDA 510(k) clearance advances Biozen’s BP1000, a handheld fingertip device designed to deliver clinically validated spot blood pressure measurements without an arm cuff or per-user calibration. ...
The event highlighted healthcare AI’s shift from experimentation to real-world deployment, with discussions on accountability, governance, workforce readiness and exhibitor solutions including Heidi and AITRICS-VC....
Scantox completes DuplexSeq technology transition, advancing error-corrected sequencing on a scalable cloud-based platform....
The Tokyo office will support Japanese biopharmaceutical companies across the product lifecycle, combining market access, medical, marketing and strategic consulting capabilities under the leadership of Junji Yokokawa. ...
India Sebia, in collaboration with CAHO Diagnostic Division, is proud to announce the launch of the Autoimmunity Masterclass Series—a six-part academic webinar initiative aimed at advancing the understanding, early diagnosis, and clinical management of autoimmune diseases....
The redesigned website expands clinical evidence, workflow guidance and access pathways for the Vivio System, an FDA-cleared non-invasive device used to measure elevated left ventricular end-diastolic pressure in outpatient settings. ...
Jointly developed by SGH, SingHealth and MOHT, LEA-Net uses patient data to identify individuals at higher risk of lower extremity amputation three to five years before foot ulcers and infections develop. ...
Healthcare leaders at the Philips APAC Innovation Summit highlighted the need for stronger hospital information systems, wider digital health adoption, improved clinical workflows, and deeper collaboration across hospitals, technology providers, research bodies, and AI developers. ...
The AI-assisted support feature is designed to help clinicians review CBCT scans more efficiently and clearly when evaluating potential periapical radiolucencies (PARLs)...
Duke-NUS researchers find that pairing a web-based decision-aid with counselling helps elderly patients with end-stage kidney disease and their caregivers make better informed treatment choices – and significantly shifts decisions towards care that prioritises comfort and quality of life....
